Diagnostics and Biotech Market Research, Industry Overview

sale

Drug Screening Market

P

2017

Drug Screening Market:

Global Drug Screening Market is expected to reach $9,447 million in 2023 from $5,214 million in 2016 registering a CAGR of 8.7%, during the forecast period, 20172023. Drug ...

Report Code : A00915 | Pages : 212 | Category : Life Sciences

Price:

~~$3,570~~ $2,106 (41% Off)

License: Cloud Access

PDF, PPT, XLS

UPDATE AVAILABLE ON DEMAND

sale

Blood Screening Market

P

2023

Blood Screening Market: Global Opportunity Analysis and Industry Forecast, 2022 - 2032

The global blood screening market was valued at $2.4 billion in 2022, and is projected to reach $4.9 billion by 2032, growing at a CAGR of 7.5% from 2023 to 2032.

Report Code : A02491 | Pages : 240 | Category : Life Sciences

Price:

~~$3,570~~ $2,499 (30% Off)

License: Cloud Access

PDF, PPT, XLS

UPDATE AVAILABLE ON DEMAND

sale

Cholesterol Screening Market

U

2026

Cholesterol Screening Market: Global Opportunity Analysis and Industry Forecast, 2023-2032

The elevated levels of cholesterol create health threats such as sharp risk of stroke & heart diseases and account for a large number of deaths. Cholesterol screening services allow early detection of the problems related to high cholesterol levels, avoiding complications and increasing the survival chances of patients.Â

Report Code : A03381 | Category : Life Sciences

Price:

~~$3,690~~ $2,583 (30% Off)

License: Cloud Access

PDF, PPT, XLS

sale

Biosimilar Testing and Development Services Market

P

2023

Biosimilar Testing and Development Services Market: Global Opportunity Analysis and Industry Forecast, 2022 - 2032

The global biosimilar testing and development services market was valued at $2.5 billion in 2022, and is projected to reach $7.8 billion by 2032, growing at a CAGR of 12.1% from 2023 to 2032.

Report Code : A03627 | Pages : 302 | Category : Life Sciences

Price:

~~$3,570~~ $2,499 (30% Off)

License: Cloud Access

PDF, PPT, XLS

UPDATE AVAILABLE ON DEMAND

sale

Artificial Intelligence in Drug Screening Market

U

2026

Artificial Intelligence in Drug Screening Market: Global Opportunity Analysis and Industry Forecast, 2023-2032

Artificial intelligence (AI) is an area of computer science that emphasizes on the creation of intelligent computers to perform tasks like humans. Artificial intelligence offers activities such as speech recognition, learning, planning, problem solving, and others.

Report Code : A04873 | Category : Life Sciences

Price:

~~$3,690~~ $2,583 (30% Off)

License: Cloud Access

PDF, PPT, XLS

sale

Artificial Intelligence For Drug Development and Discovery Market

P

2020

Artificial Intelligence For Drug Development and Discovery Market: Global Opportunity Analysis and Industry Forecast, 2019–2027

The artificial intelligence for drug discovery and development market was valued at $520 million in 2019 and is projected to reach $4,815 million by 2027, registering a CAGR of 31.6% from 2020 to 2027.

Report Code : A04876 | Pages : 210 | Category : Life Sciences

Price:

~~$3,456~~ $2,592 (25% Off)

License: Cloud Access

PDF, PPT, XLS

UPDATE AVAILABLE ON DEMAND

sale

Drug Screening Laboratory Services Market

P

2020

Drug Screening Laboratory Services Market: Global Opportunity Analysis and Industry Forecast, 2020-2027 by Service type, (Workplace Drug Testing and Clinical Toxicology Testing), Sample Type (Urine, Oral Fluid, Hair and Others), End User (Retail, Oil & Gas, Transportation, Staffing, Government, Other Workplace, Hospital Laboratories, Clinical Laboratories, and Other Laboratories): Global Opportunity Analysis and Industry Forecast, 2020-2027

The global drug screening laboratory services market size was valued at $6,720 million in 2019, and is projected to reach $7,050 million by 2027, registering a CAGR of 9.4% from 2020 to 2027.

Report Code : A06642 | Pages : 220 | Category : Life Sciences

Price:

~~$3,456~~ $2,557 (26% Off)

License: Cloud Access

PDF, PPT, XLS

UPDATE AVAILABLE ON DEMAND

sale

Carrier Screening Market

P

2022

Carrier Screening Market: Global Opportunity Analysis and Industry Forecast, 2021 - 2031

The global carrier screening market was valued at $1.9 billion in 2021, and is projected to reach $6.5 billion by 2031, growing at a CAGR of 13.8% from 2022 to 2031.

Report Code : A11271 | Pages : 350 | Category : Life Sciences

Price:

~~$3,570~~ $2,499 (30% Off)

License: Cloud Access

PDF, PPT, XLS

UPDATE AVAILABLE ON DEMAND

sale

North America Biosimilar Testing and Development Services Market

P

2024

North America Biosimilar Testing and Development Services Market: Opportunity Analysis and Industry Forecast, 2022-2032

By component, the Pharmaceutical and Biopharmaceutical Companies was the dominant sub-segment with major market share in 2022 in the North America Biosimilar Testing and Development Services Market. This sub-segment is likely to follow same momentum by the end of 2032.

Report Code : * A308933 | Pages : 130 | Category : Life Sciences

Price:

~~$2,850~~ $1,995 (30% Off)

License: Cloud Access

PDF, PPT, XLS

UPDATE AVAILABLE ON DEMAND

sale

Canada Biosimilar Testing and Development Services Market

P

2024

Canada Biosimilar Testing and Development Services Market: Opportunity Analysis and Industry Forecast, 2022-2032

Canada Biosimilar Testing and Development Services Market is projected to experience high investment on various major technologies/product/services in Canada country by the end of 2032 owing to presence of key end user vertical adopting offerings at a faster pace.

Report Code : * A308934 | Pages : 81 | Category : Life Sciences

Price:

~~$2,355~~ $1,649 (30% Off)

License: Cloud Access

PDF, PPT, XLS

UPDATE AVAILABLE ON DEMAND

sale

U.S. Biosimilar Testing and Development Services Market

P

2024

U.S. Biosimilar Testing and Development Services Market: Opportunity Analysis and Industry Forecast, 2022-2032

The U.S. Biosimilar Testing and Development Services Market segment End User is expected to witness highest CAGR during the forecast period. The report provides insights about opportunities that would help the market to expand in future.

Report Code : * A308935 | Pages : 84 | Category : Life Sciences

Price:

~~$2,355~~ $1,649 (30% Off)

License: Cloud Access

PDF, PPT, XLS

UPDATE AVAILABLE ON DEMAND

sale

Mexico Biosimilar Testing and Development Services Market

P

2024

Mexico Biosimilar Testing and Development Services Market: Opportunity Analysis and Industry Forecast, 2022-2032

The Mexico Biosimilar Testing and Development Services Market is expected to expand at a promising compound annual growth rate (CAGR) between 2023 to 2032. The Mexico Biosimilar Testing and Development Services Market growth is attributed to various driving factors and revenue opportunities.

Report Code : * A308936 | Pages : 76 | Category : Life Sciences

Price:

~~$2,355~~ $1,649 (30% Off)

License: Cloud Access

PDF, PPT, XLS

UPDATE AVAILABLE ON DEMAND

sale

Europe Biosimilar Testing and Development Services Market

P

2024

Europe Biosimilar Testing and Development Services Market: Opportunity Analysis and Industry Forecast, 2022-2032

The Europe Biosimilar Testing and Development Services Market achieved significant revenue share in base year of analysis. The Europe Biosimilar Testing and Development Services Market size is expected to account for a considerable growth rate between 2023 to 2032.

Report Code : * A308937 | Pages : 120 | Category : Life Sciences

Price:

~~$2,850~~ $1,995 (30% Off)

License: Cloud Access

PDF, PPT, XLS

UPDATE AVAILABLE ON DEMAND

sale

Germany Biosimilar Testing and Development Services Market

P

2024

Germany Biosimilar Testing and Development Services Market: Opportunity Analysis and Industry Forecast, 2022-2032

The Germany Biosimilar Testing and Development Services Market is expected to expand at a promising compound annual growth rate (CAGR) between 2023 to 2032. The Germany Biosimilar Testing and Development Services Market growth is attributed to various driving factors and revenue opportunities.

Report Code : * A308938 | Pages : 77 | Category : Life Sciences

Price:

~~$2,355~~ $1,649 (30% Off)

License: Cloud Access

PDF, PPT, XLS

UPDATE AVAILABLE ON DEMAND

sale

France Biosimilar Testing and Development Services Market

P

2024

France Biosimilar Testing and Development Services Market: Opportunity Analysis and Industry Forecast, 2022-2032

The France Biosimilar Testing and Development Services Market study provides detailed analysis on major drivers, restraints, trends, opportunities, and key player strategies impacting overall performance of market throughout the forecast period.

Report Code : * A308939 | Pages : 80 | Category : Life Sciences

Price:

~~$2,355~~ $1,649 (30% Off)

License: Cloud Access

PDF, PPT, XLS

UPDATE AVAILABLE ON DEMAND

sale

UK Biosimilar Testing and Development Services Market

P

2024

UK Biosimilar Testing and Development Services Market: Opportunity Analysis and Industry Forecast, 2022-2032

In market End User, Pharmaceutical and Biopharmaceutical Companies holds the largest revenue share during the analysis period and End User is expected to exhibit the highest CAGR over the analysis period.

Report Code : * A308940 | Pages : 70 | Category : Life Sciences

Price:

~~$2,355~~ $1,649 (30% Off)

License: Cloud Access

PDF, PPT, XLS

UPDATE AVAILABLE ON DEMAND

sale

Spain Biosimilar Testing and Development Services Market

P

2024

Spain Biosimilar Testing and Development Services Market: Opportunity Analysis and Industry Forecast, 2022-2032

Spain Biosimilar Testing and Development Services Market size is projected to increase at a lucrative rate during the forecast period. The Spain Biosimilar Testing and Development Services Market ...

Report Code : * A308941 | Pages : 70 | Category : Life Sciences

Price:

~~$2,355~~ $1,649 (30% Off)

License: Cloud Access

PDF, PPT, XLS

UPDATE AVAILABLE ON DEMAND

sale

Italy Biosimilar Testing and Development Services Market

P

2024

Italy Biosimilar Testing and Development Services Market: Opportunity Analysis and Industry Forecast, 2022-2032

The Italy Biosimilar Testing and Development Services Market segment End User is expected to witness highest CAGR during the forecast period. The report provides insights about opportunities that would help the market to expand in future.

Report Code : * A308942 | Pages : 74 | Category : Life Sciences

Price:

~~$2,355~~ $1,649 (30% Off)

License: Cloud Access

PDF, PPT, XLS

UPDATE AVAILABLE ON DEMAND

sale

Asia-Pacific Biosimilar Testing and Development Services Market

P

2024

Asia-Pacific Biosimilar Testing and Development Services Market: Opportunity Analysis and Industry Forecast, 2022-2032

In market by End User, Contract Research Organizations is expected to witness highest CAGR during the forecast period. The report provides insights about factors that affect the market in positive and negative manner.

Report Code : * A308943 | Pages : 117 | Category : Life Sciences

Price:

~~$2,670~~ $1,869 (30% Off)

License: Cloud Access

PDF, PPT, XLS

UPDATE AVAILABLE ON DEMAND

sale

China Biosimilar Testing and Development Services Market

P

2024

China Biosimilar Testing and Development Services Market: Opportunity Analysis and Industry Forecast, 2022-2032

The China Biosimilar Testing and Development Services Market report covers the drivers, restraints, and opportunities of the market. It focuses on the current market strategies adopted by the ...

Report Code : * A308944 | Pages : 77 | Category : Life Sciences

Price:

~~$2,175~~ $1,523 (30% Off)

License: Cloud Access

PDF, PPT, XLS

UPDATE AVAILABLE ON DEMAND

sale

Japan Biosimilar Testing and Development Services Market

P

2024

Japan Biosimilar Testing and Development Services Market: Opportunity Analysis and Industry Forecast, 2022-2032

The End User dominated the market with highest revenue share over the analysis period. The section Top Investment Pockets from report provides insights about most lucrative segment for investment in the market.

Report Code : * A308945 | Pages : 83 | Category : Life Sciences

Price:

~~$2,175~~ $1,523 (30% Off)

License: Cloud Access

PDF, PPT, XLS

UPDATE AVAILABLE ON DEMAND

sale

India Biosimilar Testing and Development Services Market

P

2024

India Biosimilar Testing and Development Services Market: Opportunity Analysis and Industry Forecast, 2022-2032

The End User segment in India Biosimilar Testing and Development Services Market is expected to garner considerable share in terms of value and volume during the forecast period.

Report Code : * A308946 | Pages : 86 | Category : Life Sciences

Price:

~~$2,175~~ $1,523 (30% Off)

License: Cloud Access

PDF, PPT, XLS

UPDATE AVAILABLE ON DEMAND

sale

Australia Biosimilar Testing and Development Services Market

P

2024

Australia Biosimilar Testing and Development Services Market: Opportunity Analysis and Industry Forecast, 2022-2032

The End User has the highest CAGR over the analysis period. The section Top Winning Strategies from report provides insights about most frequently adopted strategies by key players in the market.

Report Code : * A308947 | Pages : 86 | Category : Life Sciences

Price:

~~$2,175~~ $1,523 (30% Off)

License: Cloud Access

PDF, PPT, XLS

UPDATE AVAILABLE ON DEMAND

sale

South Korea Biosimilar Testing and Development Services Market

P

2024

South Korea Biosimilar Testing and Development Services Market: Opportunity Analysis and Industry Forecast, 2022-2032

The End User segment in South Korea Biosimilar Testing and Development Services Market is expected to garner considerable share in terms of value and volume during the forecast period.

Report Code : * A308948 | Pages : 70 | Category : Life Sciences

Price:

~~$2,175~~ $1,523 (30% Off)

License: Cloud Access

PDF, PPT, XLS

UPDATE AVAILABLE ON DEMAND

sale

LAMEA Biosimilar Testing and Development Services Market

P

2024

LAMEA Biosimilar Testing and Development Services Market: Opportunity Analysis and Industry Forecast, 2022-2032

The LAMEA Biosimilar Testing and Development Services Market is mainly segmented on the basis of type and end user. The LAMEA Biosimilar Testing and Development Services Market hold the largest revenue share throughout the analysis period.

Report Code : * A308949 | Pages : 121 | Category : Life Sciences

Price:

~~$2,670~~ $1,869 (30% Off)

License: Cloud Access

PDF, PPT, XLS

UPDATE AVAILABLE ON DEMAND

Diagnostics and Biotech

Filter by Region

Filter by Discounts

Filter by Category

Global Drug Screening Market is expected to reach $9,447 million in 2023 from $5,214 million in 2016 registering a CAGR of 8.7%, during the forecast period, 20172023. Drug ...

The global blood screening market was valued at $2.4 billion in 2022, and is projected to reach $4.9 billion by 2032, growing at a CAGR of 7.5% from 2023 to 2032.

The global biosimilar testing and development services market was valued at $2.5 billion in 2022, and is projected to reach $7.8 billion by 2032, growing at a CAGR of 12.1% from 2023 to 2032.

Artificial intelligence (AI) is an area of computer science that emphasizes on the creation of intelligent computers to perform tasks like humans. Artificial intelligence offers activities such as speech recognition, learning, planning, problem solving, and others.

The artificial intelligence for drug discovery and development market was valued at $520 million in 2019 and is projected to reach $4,815 million by 2027, registering a CAGR of 31.6% from 2020 to 2027.

The global drug screening laboratory services market size was valued at $6,720 million in 2019, and is projected to reach $7,050 million by 2027, registering a CAGR of 9.4% from 2020 to 2027.

The global carrier screening market was valued at $1.9 billion in 2021, and is projected to reach $6.5 billion by 2031, growing at a CAGR of 13.8% from 2022 to 2031.

By component, the Pharmaceutical and Biopharmaceutical Companies was the dominant sub-segment with major market share in 2022 in the North America Biosimilar Testing and Development Services Market. This sub-segment is likely to follow same momentum by the end of 2032.

Canada Biosimilar Testing and Development Services Market is projected to experience high investment on various major technologies/product/services in Canada country by the end of 2032 owing to presence of key end user vertical adopting offerings at a faster pace.

The U.S. Biosimilar Testing and Development Services Market segment End User is expected to witness highest CAGR during the forecast period. The report provides insights about opportunities that would help the market to expand in future.

The Mexico Biosimilar Testing and Development Services Market is expected to expand at a promising compound annual growth rate (CAGR) between 2023 to 2032. The Mexico Biosimilar Testing and Development Services Market growth is attributed to various driving factors and revenue opportunities.

The Europe Biosimilar Testing and Development Services Market achieved significant revenue share in base year of analysis. The Europe Biosimilar Testing and Development Services Market size is expected to account for a considerable growth rate between 2023 to 2032.

The Germany Biosimilar Testing and Development Services Market is expected to expand at a promising compound annual growth rate (CAGR) between 2023 to 2032. The Germany Biosimilar Testing and Development Services Market growth is attributed to various driving factors and revenue opportunities.

The France Biosimilar Testing and Development Services Market study provides detailed analysis on major drivers, restraints, trends, opportunities, and key player strategies impacting overall performance of market throughout the forecast period.

In market End User, Pharmaceutical and Biopharmaceutical Companies holds the largest revenue share during the analysis period and End User is expected to exhibit the highest CAGR over the analysis period.

Spain Biosimilar Testing and Development Services Market size is projected to increase at a lucrative rate during the forecast period. The Spain Biosimilar Testing and Development Services Market ...

The Italy Biosimilar Testing and Development Services Market segment End User is expected to witness highest CAGR during the forecast period. The report provides insights about opportunities that would help the market to expand in future.

In market by End User, Contract Research Organizations is expected to witness highest CAGR during the forecast period. The report provides insights about factors that affect the market in positive and negative manner.

The China Biosimilar Testing and Development Services Market report covers the drivers, restraints, and opportunities of the market. It focuses on the current market strategies adopted by the ...

The End User dominated the market with highest revenue share over the analysis period. The section Top Investment Pockets from report provides insights about most lucrative segment for investment in the market.

The End User segment in India Biosimilar Testing and Development Services Market is expected to garner considerable share in terms of value and volume during the forecast period.

The End User has the highest CAGR over the analysis period. The section Top Winning Strategies from report provides insights about most frequently adopted strategies by key players in the market.

The End User segment in South Korea Biosimilar Testing and Development Services Market is expected to garner considerable share in terms of value and volume during the forecast period.

The LAMEA Biosimilar Testing and Development Services Market is mainly segmented on the basis of type and end user. The LAMEA Biosimilar Testing and Development Services Market hold the largest revenue share throughout the analysis period.

Global Drug Screening Market is expected to reach $9,447 million in 2023 from $5,214 million in 2016 registering a CAGR of 8.7%, during the forecast period, 20172023. Drug ...